Search for: "Bayer Pharma A G"
Results 1 - 20
of 24
Sorted by Relevance
|
Sort by Date
6 Mar 2008, 9:53 pm
District Court for the District of New Jersey (Judge Peter G. [read post]
8 Dec 2008, 6:53 pm
Miller, Gérard Sicsic and John Wilkinson. [read post]
22 Jun 2011, 4:09 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Sep 2008, 12:08 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
15 Mar 2012, 10:40 am
G. [read post]
14 Mar 2012, 6:40 am
The patentee is Bayer Corporation, and the applicant for an compulsory license is Natco Pharma Limited, an Indian generic pharmaceuticals company. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
10 Sep 2010, 1:21 am
Bayer AG, 05-2851-cv(L) Supreme Court, Nassau County Court Rejects Service on 11-Year Old in Foreclosure Action Citibank Trust Bank FSB v. [read post]
12 Jan 2022, 8:38 am
“In 2012, India’s first ever compulsory license was granted by the Indian Patent Office to Natco Pharma for generic production of Bayer Corp’s Nexaver® (Sorafenib Tosylate), a life-saving medicine used for treating liver and kidney cancer. [read post]
29 Jul 2021, 8:04 am
’” Bayer Pharma AG v. [read post]
17 Feb 2010, 2:29 pm
Bayer Healthcare LLC, No. 1:10-cv-00001-SLR (D. [read post]
19 Aug 2008, 10:55 am
"As an expert who blogs occasionally," says security expert Kevin G. [read post]
22 Oct 2015, 8:42 am
FDA beforeas the latest First Amendment follow-up action to Amarin Pharma, Inc. v. [read post]
7 Oct 2019, 11:12 am
IP Enforcement GuestKat Peter Ling, in‘There is No Such Thing as a Free Launch – CJEU Does Not Follow AG on Compensation for Wrongful PI' , reports and critically comments on the latest ruling in Bayer Pharma case C-688/17. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
4 Apr 2008, 1:00 am
: (creativecommons.org), Neil Netanel’s copyright paradox: (Patry Copyright Blog), Isn’t it ironic: TechCrunch blames the music industry for the dangerous ideas of Lessig and the free culture movement: (IPcentral.com) CFP: First interdisciplinary research workshop on free culture: (creativecommons.org), Of limitations, exceptions and verse (WIPO copyright committee): (KEI) Pharma & Biotech Pharma & Biotech - General … [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]
